{
    "root": "d1afd534-ca74-462d-9cbb-03e54547cd9a",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "RIVAROXABAN",
    "value": "20250517",
    "ingredients": [
        {
            "name": "RIVAROXABAN",
            "code": "9NDF7JZ4M3"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "D&C YELLOW NO. 10 ALUMINUM LAKE",
            "code": "CQ3XH3DET6"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        }
    ],
    "indications": "Rivaroxaban tablets are a factor Xa inhibitor indicated: to reduce the risk of major cardiovascular events in patients with coronary artery disease (CAD) (1.7) to reduce the risk of major thrombotic vascular events in patients with peripheral artery disease (PAD), including patients after recent lower extremity revascularization due to symptomatic PAD (1.8)",
    "contraindications": "CAD or PAD : 2.5 mg orally twice daily with or without food, in combination with aspirin (75-100 mg) once daily (2.1)",
    "warningsAndPrecautions": "Rivaroxaban tablets, USP are available in the strengths and packages listed below:\n                  \n                     2.5 mg tablets: Yellow color, round shaped, film coated tablets, debossed with “T” on one side and “2.5” on the other side.\n                  \n                  NDC 31722-496-60 Bottle containing 60 tablets\n                  NDC 31722-496-18 Bottle containing 180 tablets\n                  Storage of tablets:\n                  Store at room temperature between 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].\n                  Keep out of the reach of children.",
    "adverseReactions": "Rivaroxaban tablets are contraindicated in patients with:\n                  \n                     active pathological bleeding [see Warnings and Precautions (5.2)] \n                     \n                     severe hypersensitivity reaction to rivaroxaban tablets (e.g., anaphylactic reactions) [see Adverse Reactions (6.2)]"
}